2024

Cross-cultural validity and reliability of the comprehensive assessment of acceptance and commitment therapy processes (CompACT) in people with multiple sclerosis
Giovannetti A, Rosato R, Galán I, Toscano A, Anglada E, Menendez R, Hoyer J, Confalonieri P, Giordano A, Pakenham K, Pöttgen J, Solari A
QUAL LIFE RES. 2024;33(5):1359-1371.

Effectiveness of a digital lifestyle management intervention (levidex) to improve quality of life in people with multiple sclerosis: results of a randomized controlled trial
Meyer B, Betz L, Jacob G, Krause N, Riemann-Lorenz K, Gold S, Pöttgen J, Heesen C
BMC NEUROL. 2024;24(1):.

Nutrition Knowledge and Food Literacy Among Persons with Multiple Sclerosis-Development and Validation of Patient-Reported Outcome Measures
Riemann-Lorenz K, Seddiq Zai S, Daubmann A, Pöttgen J, Heesen C
NUTRIENTS. 2024;16(23):.

Factors affecting driving performance in patients with Multiple Sclerosis - still an open question
Seddiq Zai S, das Nair R, Heesen C, Buhmann C, Pedersen A, Pöttgen J
FRONT NEUROL. 2024;15:1369143.

Education for fatigue management in people with multiple sclerosis: Systematic review and meta-analysis
Wendebourg M, Poettgen J, Finlayson M, Gonzalez-Lorenzo M, Heesen C, Köpke S, Giordano A
EUR J NEUROL. 2024;31(12):e16452.

2023

Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms
Baetge S, Filser M, Renner A, Raithel L, Lau S, Pöttgen J, Penner I
J NEUROL. 2023;270(6):3058-3071.

Health behaviors of people with multiple sclerosis and its associations with MS related outcomes: a German clinical cohort
Goldin K, Riemann-Lorenz K, Daubmann A, Pöttgen J, Krause N, Schröder H, Heesen C
FRONT NEUROL. 2023;14:1172419.

Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial
Gold S, Friede T, Meyer B, Moss-Morris R, Hudson J, Asseyer S, Bellmann-Strobl J, Leisdon A, Ißels L, Ritter K, Schymainski D, Pomeroy H, Lynch S, Cozart J, Thelen J, Román C, Cadden M, Guty E, Lau S, Pöttgen J, Ramien C, Seddiq-Zai S, Kloidt A, Wieditz J, Penner I, Paul F, Sicotte N, Bruce J, Arnett P, Heesen C
LANCET DIGIT HEALTH. 2023;5(10):e668-e678.

Topological reorganization of brain network might contribute to the resilience of cognitive functioning in mildly disabled relapsing remitting multiple sclerosis
Has Silemek A, Nolte G, Pöttgen J, Engel A, Heesen C, Gold S, Stellmann J
J NEUROSCI RES. 2023;101(1):143-161.

Mobile health interventions in multiple sclerosis: A systematic review
Heesen C, Berger T, Riemann-Lorenz K, Krause N, Friede T, Pöttgen J, Meyer B, Lühmann D
MULT SCLER J. 2023;29(14):1709-1720.

eHealth für MS-Betroffene mit Fatigue
Pöttgen J, Penner I
PiD-Psychother Dialog. 2023;2023(24):1-4.

Non-pharmacological randomized intervention trial for the management of neuropsychological symptoms in outpatients with progressive multiple sclerosis
Renner A, Bätge S, Filser M, Lau S, Pöttgen J, Penner I
APPL NEUROPSYCH-ADUL. 2023 [Epub ahead of print];1-13.

Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis
Tilsley P, Strohmeyer I, Heinrich I, Rosenthal F, Patra S, Schulz K, Rosenkranz S, Ramien C, Pöttgen J, Heesen C, Has A, Gold S, Stellmann J
J NEUROL. 2023;270(10):4876-4888.

2022

Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson's Disease?
Fründt O, Fadhel M, Heesen C, Seddiq Zai S, Gerloff C, Vettorazzi E, Pöttgen J, Buhmann C
J PARKINSON DIS. 2022;12(7):2261-2275.

Cross-Country Adaptation of a Psychological Flexibility Measure: The Comprehensive Assessment of Acceptance and Commitment Therapy Processes
Giovannetti A, Pöttgen J, Anglada E, Menéndez R, Hoyer J, Giordano A, Pakenham K, Galán I, Solari A
INT J ENV RES PUB HE. 2022;19(6):.

'That would have been the perfect thing after diagnosis': development of a digital lifestyle management application in multiple sclerosis
Krause N, Riemann-Lorenz K, Rahn A, Pöttgen J, Köpke S, Meyer B, Thale F, Temmes H, van de Loo M, Gold S, Heesen C
THER ADV NEUROL DISO. 2022;15:.

Managing neuropsychological impairment in multiple sclerosis - Controlled study on a standardized metacognitive intervention (MaTiMS)
Pöttgen J, Friede T, Lau S, Gold S, Letsch C, Bender G, Flachenecker P, Heesen C, Penner I
MULT SCLER RELAT DIS. 2022;59:.

Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
Seddiq Zai S, Heesen C, Buhmann C, das Nair R, Pöttgen J
FRONT NEUROL. 2022;13:.

Validation of the German eHealth impact questionnaire for online health information users affected by multiple sclerosis
Sippel A, Riemann-Lorenz K, Pöttgen J, Wiedemann R, Drixler K, Bitzer E, Holmberg C, Lezius S, Heesen C
BMC MED INFORM DECIS. 2022;22(1):.

2021

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
Häußler V, Ufer F, Pöttgen J, Wolschke C, Friese M, Kröger N, Heesen C, Stellmann J
ANN CLIN TRANSL NEUR. 2021;8(6):1269-1278.

Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)-Results of a Pilot Randomized Controlled Trial
Heinrich I, Rosenthal F, Patra S, Schulz K, Welsch G, Vettorazzi E, Rosenkranz S, Stellmann J, Ramien C, Pöttgen J, Gold S, Heesen C
FRONT NEUROL. 2021;12:644533.

Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1)
Krause N, Riemann-Lorenz K, Steffen T, Rahn A, Pöttgen J, Stellmann J, Köpke S, Friede T, Icks A, Vomhof M, Temmes H, van de Loo M, Gold S, Heesen C
BMJ OPEN. 2021;11(2):e041720.

Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis
Stellmann J, Wanke N, Maarouf A, Gellißen S, Heesen C, Audoin B, Gold S, Zaaraoui W, Poettgen J
NEUROIMAGE-CLIN. 2021;30:.

2020

Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple Sclerosis
Golde S, Heine J, Pöttgen J, Mantwill M, Lau S, Wingenfeld K, Otte C, Penner I, Engel A, Heesen C, Stellmann J, Dziobek I, Finke C, Gold S
FRONT NEUROL. 2020;11:507.

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
Has Silemek A, Fischer L, Pöttgen J, Penner I, Engel A, Heesen C, Gold S, Stellmann J
NEUROIMAGE-CLIN. 2020;25:102177.

Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis: A Systematic Review
Pöttgen J, van de Vis W, van Nunen A, Rose A, Engelbrecht J, Pirard M, Lau S, Heesen C, Köpke S
Int J MS Care. 2020;22(6):276-284.

Aerobic Exercise Induces Functional and Structural Reorganization of CNS Networks in Multiple Sclerosis: A Randomized Controlled Trial
Stellmann J, Maarouf A, Schulz K, Baquet L, Pöttgen J, Patra S, Penner I, Gellißen S, Ketels G, Besson P, Ranjeva J, Guye M, Nolte G, Engel A, Audoin B, Heesen C, Gold S
FRONT HUM NEUROSCI. 2020;14:255.

Frequent neurocognitive deficits after recovery from mild COVID-19
Woo M, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo M, Gerloff C, Heesen C, Schulze zur Wiesch J, Friese M
BRAIN COMMUN. 2020;2(2):fcaa205.

Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals
Zhai Y, Nasseri N, Pöttgen J, Gezhelbash E, Heesen C, Stellmann J
FRONT NEUROL. 2020;11:688.

2019

Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire
Beckmann H, Augustin M, Heesen C, Poettgen J, Blome C
MULT SCLER RELAT DIS. 2019;28:256-261.

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)
Johnen A, Bürkner P, Landmeyer N, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König I, Klotz L, Hoshi M, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh F, Kümpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl U, Zipp F, Hemmer B, Meuth S, Gold R, Wiendl H, Salmen A
J NEUROL. 2019;266(2):386-397.

In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients
Pust G, Pöttgen J, Randerath J, Lau S, Heesen C, Gold S, Penner I
J NEUROL. 2019;266(7):1663-1673.

Impairment and restrictions in possibly benign multiple sclerosis
Schaefer L, Poettgen J, Fischer A, Gold S, Stellmann J, Heesen C
BRAIN BEHAV. 2019;9(4):e01259.

2018

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial
Baquet L, Hasselmann H, Patra S, Stellmann J, Vettorazzi E, Engel A, Rosenkranz S, Poettgen J, Gold S, Schulz K, Heesen C
PEERJ. 2018;6:e6037.

The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study
Filser M, Schreiber H, Pöttgen J, Ullrich S, Lang M, Penner I
J NEUROL. 2018;265(11):2587-2593.

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey
Giordano A, Liethmann K, Köpke S, Poettgen J, Rahn A, Drulovic J, Beckmann Y, Sastre-Garriga J, Galea I, Heerings M, Jongen P, Vettorazzi E, Solari A, Heesen C
PLOS ONE. 2018;13(11):e0208004.

Patterns of association between neuropsychological task performance and structural connectomes in mildly disabled RRMS
Has Silemek A, Fischer L, Heesen C, Pöttgen J, Gold S, Stellmann J
2018. Multiple Sclerosis Journal. S2. Aufl. 328–529.

Perceptions on the value of bodily functions in multiple sclerosis
Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Friedemann P, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann J
ACTA NEUROL SCAND. 2018;137(3):356-362.

Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis
Pöttgen J, Moss-Morris R, Wendebourg J, Feddersen L, Lau S, Köpke S, Meyer B, Friede T, Penner I, Heesen C, Gold S
J NEUROL NEUROSUR PS. 2018;89(9):970-976.

Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review
Pöttgen J, Rose A, van de Vis W, Engelbrecht J, Pirard M, Lau S, Heesen C, Köpke S
PLOS ONE. 2018;13(2):e0193381.

2017

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0)
Heesen C, Pöttgen J, Rahn A, Liethmann K, Kasper J, Vahter L, Drulovic J, Van Nunen A, Wilkie D, Beckmann Y, Paul F, Giordano A, Solari A
MULT SCLER RELAT DIS. 2017;18:186-195.

A new graphical format to communicate treatment effects to patients: A web-based randomized controlled trial
Kasper J, van de Roemer A, Pöttgen J, Rahn A, Backhus I, Bay Y, Köpke S, Heesen C
HEALTH EXPECT. 2017;20(4):797-804.

Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study
Köpke S, Kasper J, Flachenecker P, Meißner H, Brandt A, Hauptmann B, Bender G, Backhus I, Rahn A, Pöttgen J, Vettorazzi E, Heesen C
CLIN REHABIL. 2017;31(2):250-261.

No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis
Stellmann J, Young K, Vettorazzi E, Pöttgen J, Heesen C
EUR J NEUROL. 2017;24(6):851-857.

Patient education for people with multiple sclerosis-associated fatigue: A systematic review
Wendebourg M, Heesen C, Finlayson M, Meyer B, Pöttgen J, Köpke S
PLOS ONE. 2017;12(3):e0173025.

2016

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
Stellmann J, Cetin H, Young K, Hodecker S, Pöttgen J, Bittersohl D, Hassenstein A, Oberwahrenbrock T, Heesen C, Siemonsen S
BRAIN BEHAV. 2016;7(2):e00614.

Development and Feasibility of an Evidence-Based Patient Education Program for Managing Fatigue in Multiple Sclerosis: The "Fatigue Management in MS" Program (FatiMa)
Wendebourg M, Feddersen L, Lau S, Köpke S, Moss-Morris R, Heesen C, Pöttgen J
Int J MS Care. 2016;18(3):129-37.

2015

Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires
Fischer A, Fischer M, Nicholls R, Lau S, Poettgen J, Patas K, Heesen C, Gold S
BRAIN BEHAV. 2015;5(9):e00365.

An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.
Fischer A, Schröder J, Vettorazzi E, Wolf O, Pöttgen J, Lau S, Heesen C, Moritz S, Gold S
LANCET PSYCHIAT. 2015;2(3):217-223.

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)-Development of an Outcome Instrument for Educational Interventions
Heesen C, Kasper J, Fischer K, Köpke S, Rahn A, Backhus I, Poettgen J, Vahter L, Drulovic J, Van Nunen A, Beckmann Y, Liethmann K, Giordano A, Fulcher G, Solari A
PLOS ONE. 2015;10(10):e0138364.

Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention
Pöttgen J, Lau S, Penner I, Heesen C, Moritz S
Int J MS Care. 2015;17(3):130-7.

Stammzelltransplantation bei Multipler Sklerose. Hamburger Erfahrungen und internationaler Forschungsstand
Stellmann J, Stürner K, Ufer F, Havemeister S, Pöttgen J, Ayuketang F, Kröger N, Friese M, Heesen C
NERVENARZT. 2015;86(8):989-96.

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients
Stellmann J, Young K, Pöttgen J, Dorr M, Heesen C
MULT SCLER J-EXP TRA. 2015;1(1):1-8.

2014

Magnetic resonance imaging in multiple sclerosis--patients' experiences, information interests and responses to an education programme
Brand J, Köpke S, Kasper J, Rahn A, Backhus I, Poettgen J, Stellmann J, Siemonsen S, Heesen C
PLOS ONE. 2014;9(11):e113252.

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial
Köpke S, Kern S, Ziemssen T, Berghoff M, Kleiter I, Marziniak M, Paul F, Vettorazzi E, Pöttgen J, Fischer K, Kasper J, Heesen C
J NEUROL NEUROSUR PS. 2014;85(4):411-8.

A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients
Stellmann J, Vettorazzi E, Poettgen J, Heesen C
J NEUROL SCI. 2014;346(1-2):99-106.

2013

Impaired social cognition in multiple sclerosis
Pöttgen J, Dziobek I, Reh S, Heesen C, Gold S
J NEUROL NEUROSUR PS. 2013;84(5):523-8.

2012

Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Heesen C, Köpke S, Kasper J, Poettgen J, Tallner A, Mohr D, Gold S
EXPERT REV NEUROTHER. 2012;12(9):1089-1100.

2011

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C
MULT SCLER J. 2011;17(8):1002-1009.

Letzte Aktualisierung aus dem FIS: 20.12.2024 - 23:36 Uhr